Page last updated: 2024-09-03
etomoxir and Adenocarcinoma
etomoxir has been researched along with Adenocarcinoma in 1 studies
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Huang, G; Li, J; Liu, J; Miao, P; Song, S; Sun, X; Zhang, T; Zhao, L; Zhao, S; Zhao, X; Zhou, X | 1 |
Other Studies
1 other study(ies) available for etomoxir and Adenocarcinoma
Article | Year |
---|---|
Inhibition of lipolysis by mercaptoacetate and etomoxir specifically sensitize drug-resistant lung adenocarcinoma cell to paclitaxel.
Topics: Adenocarcinoma; Antineoplastic Agents; Carbon Dioxide; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Enzyme Inhibitors; Epoxy Compounds; Glucose; Glycolysis; Humans; Lipolysis; Lung Neoplasms; Oleic Acid; Oxidative Phosphorylation; Paclitaxel; Thioglycolates | 2013 |